![Lotfi Yelles Chaouche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lotfi Yelles Chaouche currently works at Apaxen SA, as Director from 2019, InhaTarget Therapeutics SRL, as Director, NeuVasQ Biotechnologies SA, as Director, and Gepeceron SARL, as Director.
Mr. Yelles Chaouche also formerly worked at EGEIRO Pharma, as Chairman in 2021 and ChromaCure SA, as Director.
Mr. Yelles Chaouche received his undergraduate degree and graduate degree from Institut Supérieur de l'Aéronautique et de l'Espace.
| Sociétés | Poste | Début |
|---|---|---|
Inhatarget Therapeutics
 Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Directeur/Membre du Conseil | - |
Apaxen SA
 Apaxen SA BiotechnologyHealth Technology Develops anti-inflammatory therapeutics with a primary focus on pulmonary arterial hypertension | Directeur/Membre du Conseil | 29/07/2019 |
NeuVasQ Biotechnologies SA
 NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treating neurological disorders by repairing neurovascular function | Directeur/Membre du Conseil | - |
Gepeceron SARL
 Gepeceron SARL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical & natural sciences | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Theodorus Investment Funds
 Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Private Equity Investor | 01/06/2023 |
| THERAVET SA | Président | 20/12/2021 |
ChromaCure SA
 ChromaCure SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules against cancers | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 8 |
|---|---|
Institut Supérieur de l'Aéronautique et de l'Espace
 Institut Supérieur de l'Aéronautique et de l'Espace Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Finance |
TheraVet SA
 TheraVet SA Miscellaneous Commercial ServicesCommercial Services Develops new treatments and drugs for animals suffering from osteoarticular diseases | Commercial Services |
ChromaCure SA
ChromaCure SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules against cancers | Health Technology |
Apaxen SA
Apaxen SA BiotechnologyHealth Technology Develops anti-inflammatory therapeutics with a primary focus on pulmonary arterial hypertension | Health Technology |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Health Technology |
NeuVasQ Biotechnologies SA
NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treating neurological disorders by repairing neurovascular function | Health Technology |
Gepeceron SARL
Gepeceron SARL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in other physical & natural sciences | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
